MGRM

About Monogram Orthopaedics, Inc.

Monogram Orthopaedics, Inc. (MGRM) specializes in developing technologies that enable the mass personalization and optimization of orthopedic implants. The company's strategy involves producing and marketing a comprehensive array of tools for reconstructive joint replacement surgeries, including advanced robotic surgical equipment with integrated software, specialized orthopedic implants, tissue ablation instruments, navigation consumables, and other related surgical accessories. Demonstrating its capabilities, a prototype robot precisely places optimized implants into synthetic bone specimens by executing carefully planned surgical pathways. The company was founded in 2016 and was initially known as Monogram Arthroplasty Inc. before officially rebranding to Monogram Orthopaedics, Inc. in March 2017. Its corporate headquarters are located in Austin, Texas.

CEO: Benjamin Sexson
IPO Date: May 18, 2023

Market Data

Open: $6.00
High: $6.00
Low: $6.00
Volume: 1.8M
52W High: $6.43
52W Low: $1.92

Valuation

Market Cap: $244M
Enterprise Value: $231M

Financials

Free Cash Flow: $-14M
Revenue: $0
Net Income: $-16M
Cash: $16M
Debt: $364k

Events

EarningsNov 13

EPS est. -0.1 · actual -0.16